NCT07123181 Oregano and Basil Leaves and Coronary Artery Disease
| NCT ID | NCT07123181 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shahid Beheshti University of Medical Sciences |
| Condition | Acute Coronary Syndromes |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-09-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-09-01 with a primary completion date of 2026-09-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with unstable angina Exclusion Criteria: * Patients diagnosed with STEMI * Patients undergoing coronary artery bypass grafting * Liver cirrhosis and advanced chronic kidney disease (CKD 5) * Having known inflammatory and autoimmune diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or taking glucocorticoid medications * Pregnancy or breastfeeding
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07123181 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 75 Years, studying Acute Coronary Syndromes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07123181 currently recruiting?
Yes, NCT07123181 is actively recruiting participants. Contact the research team at behnazpourrajab@gmail.com for enrollment information.
Where is the NCT07123181 trial being conducted?
This trial is being conducted at Tehran, Iran.
Who is sponsoring the NCT07123181 clinical trial?
NCT07123181 is sponsored by Shahid Beheshti University of Medical Sciences. The trial plans to enroll 70 participants.